Hanham Health is part of the 4PCC Research Hub that participates in approved NHS research studies through the NIHR Clinical Research Network. As part of the National Institute for Health Research, we help to provide the infrastructure that allows high-quality clinical research to take place in the NHS, so that patients can benefit from new and better treatments, and we can learn how to improve NHS healthcare for the future.

We are committed to the Department of Health’s national strategy which puts patients at the centre of all NHS related activity. To ensure that ‘patient benefit’ is not simply based on the views and options of research professionals and clinicians, the national strategy highlights the importance of involving patients, carers and the public at all stages of the research process.

Patients and public can be involved:

  • As patients/participants voluntarily taking part in clinical or other well designed studies.
  • As patients and public members working with research professionals and clinicians (e.g. doctors, nurses) and getting actively involved in the different stages of research and related activities.

For more info see

If you would like to be considered for any of our studies please let your GP know.

Current research studies:

PANDA – what are the indications for Prescribing ANtiDepressAnts that will lead to a clinical benefit?

This study is aiming to recruit around 680 (across practices in the area) people who have experienced stress, depression or low mood but are not on antidepressant medication at the moment. The study lasts for 3 months. The study is looking at who might fully benefit from antidepressants as a treatment for depression. There is some evidence that antidepressant medication may be helpful to only some people, other people may take it unnecessarily. Please make an appointment with your GP if you would like to discuss in more detail.

HIPPO – Hippocampal changes in early Alzheimer’s disease: A multimodal Magnetic Resonance Study.

The purpose of this study is to investigate whether or not new Magnetic Resonance (MR) brain imaging techniques can be used to identify patients with Alzheimer’s in the earliest stages of the disease. The potential future benefit of this is that, as new treatments are developed, they can be used in patients diagnosed earlier, before significant brain deterioration has occurred.  

TUDOR – Total Burden of Psoriasis

The study aim is to determine whether the early detection of undiagnosed Psoriatic Arthritis in people with psoriasis by an enhanced surveillance intervention compared to standard care improves outcome in physical function as measured by the Health Assessment Questionnaire.